Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide (Mounjaro) dual GIP/GLP-1 receptor agonist) 3,4 3,4 Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that produces superior weight loss compared with selective GLP-1 receptor agonists, through: Enhanced appetite suppression via dual receptor activation
Standard maintenance: - Type I-II: 0.5 mg twice per week - Type III-IV: 0.5 mg once per week - Type V-VI: 0.5 mg every 2-3 weeks Alternative approach: Some users prefer a single larger weekly dose (1.0 mg once per week instead of 0.5 mg twice per week)
Retatrutides triple-receptor mechanism addresses appetite suppression through GLP-1, nutrient partitioning through GIP, and direct fat mobilization through glucagon activation
Frequently Asked Questions How many days does it take for semaglutide to start working
The FDAs phrasing is not accidental
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 29.58
US$ 28.31
US$ 21.63
US$ 22.57
US$ 28.22
